rs104894255
Variant summary
Our verdict is Pathogenic. Variant got 22 ACMG points: 22P and 0B. PS1PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.946G>A(p.Gly316Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G316E) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 22 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.946G>A | p.Gly316Arg | missense_variant | 7/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.946G>A | p.Gly316Arg | missense_variant | 7/16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000335475.6 | c.565G>A | p.Gly189Arg | missense_variant | 7/16 | 1 | ENSP00000334497.5 | |||
KCNQ1 | ENST00000496887.7 | c.685G>A | p.Gly229Arg | missense_variant | 8/16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.502G>A | p.Gly168Arg | missense_variant | 3/11 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | KardioGenetik, Herz- und Diabeteszentrum NRW | Aug 31, 2023 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 21, 2014 | p.Gly316Arg (GGG>AGG): c.946 G>A in exon 7 of the KCNQ1 gene (NM_000218.2). The G316R mutation in the KCNQ1 gene has been reported in association with LQTS (Jongbloed et al., 2002; Tester et al., 2005). Jongbloed et al., 2002, studied 32 patients of Dutch and Belgian ancestry and identified the novel G316R mutation in one patient. This mutation segregated with the disease in the family and was not present in 100 control chromosomes (Jongbloed et al., 2002). Additionally, Tester et al., 2005, studied 88 individuals with LQTS and KCNQ1 mutations, and identified one individual with G316R. G316R results in a non-conservative amino acid substitution of Glycine at a position that is conserved across species. Mutations in the same residue (G316E, G316V) and in nearby residues (G314C, G314R, Y315N, Y315F, D317N) have been reported in association with LQTS, further supporting the functional importance of this region of the protein. Furthermore, the G316R mutation was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, G316R in the KCNQ1 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). - |
Long QT syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2022 | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 316 of the KCNQ1 protein (p.Gly316Arg). This missense change has been observed in individual(s) with clinical features of long QT syndrome (PMID: 15840476; Invitae). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly316 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19808498, 20981542). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function. ClinVar contains an entry for this variant (Variation ID: 53142). - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at